In a 6‑week, multicentre, double‑blind randomised phase 2A trial of 53 adults with moderate–severe ADHD, twice‑weekly low‑dose LSD (20 μg) was physically safe and psychologically well tolerated. However, LSD did not reduce ADHD symptoms more than placebo on the AISRS.
- Published
- Journal
- JAMA Psychiatry
- Authors
- Mueller, L., de Jesus, N. M. S., Schmid, Y., Müller, F., Becker, A. M., Klaiber, A., Straumann, I., Luethi, D., Haijen, E. C. H. M., Hurks, P. P. M., Kuypers, K. P. C., Liechti, M. E.